Literature DB >> 22238699

The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric study.

Gaetano Ierardo1, Maurizio Bossù, Desirée Tarantino, Vincenzo Trinchieri, Gian Luca Sfasciotti, Antonella Polimeni.   

Abstract

AIM.: The lactic bacteria are Gram-positive microorganisms with coccus or stick shape, which share a number of physiological and biochemical properties. Several experimental evidences suggest the possibility of using lactic acid bacterial as a preventive or therapeutic potential approaches, alternative or complementary to prevention or treatment protocols currently followed in several pathological conditions. Lactobacillus brevis is able, through the arginine-deiminase activity, to subtract the substrate (arginine) to nitric oxide synthase, and to inhibit in vitro generation of nitric oxide from rat's peritoneal macrophages. These data led us to study the in vivo L. brevis anti-inflammatory effect choosing as experimental model the gingivitis. MATERIALS AND METHODS.: In our study were examined 21 subjects, 16 males and 5 females, aged between 5 and 12 years, with marginal gingivitis problems who have been given chewing gum containing the principle to test in measure of three per day. RESULTS.: At the time T1, after treatment, 18 patients no longer showed inflammation; 2 of them had a slight inflammation and only 1 patient still showed a moderate inflammation. CONCLUSIONS.: From our research, as confirmed by clinical and laboratory investigation, results an effective anti-inflammatory action of arginine-deiminase system that some bacteria possessing.

Entities:  

Keywords:  arginine-deiminase; gingivitis; lactobacillus brevis

Year:  2010        PMID: 22238699      PMCID: PMC3254373     

Source DB:  PubMed          Journal:  Ann Stomatol (Roma)        ISSN: 1824-0852


  17 in total

1.  Clinical parameters as predictors of destructive periodontal disease activity.

Authors:  A D Haffajee; S S Socransky; J M Goodson
Journal:  J Clin Periodontol       Date:  1983-05       Impact factor: 8.728

2.  Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.

Authors:  S Ulisse; P Gionchetti; S D'Alò; F P Russo; I Pesce; G Ricci; F Rizzello; U Helwig; M G Cifone; M Campieri; C De Simone
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

3.  Aspartate aminotransferase (AST) levels in human periodontium-derived cells.

Authors:  F Mizuho; H Mori; S Deguchi; Y Ogawa; T Hori
Journal:  J Periodontol       Date:  1996-08       Impact factor: 6.993

4.  Relationship between levels of aspartate aminotransferase in gingival crevicular fluid and gingival inflammation.

Authors:  G R Persson; T A DeRouen; R C Page
Journal:  J Periodontal Res       Date:  1990-01       Impact factor: 4.419

Review 5.  Probiotic spectra of lactic acid bacteria (LAB).

Authors:  A S Naidu; W R Bidlack; R A Clemens
Journal:  Crit Rev Food Sci Nutr       Date:  1999-01       Impact factor: 11.176

6.  Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease.

Authors:  D N Della Riccia; F Bizzini; M G Perilli; A Polimeni; V Trinchieri; G Amicosante; M G Cifone
Journal:  Oral Dis       Date:  2007-07       Impact factor: 3.511

Review 7.  Gingivitis.

Authors:  R C Page
Journal:  J Clin Periodontol       Date:  1986-05       Impact factor: 8.728

8.  Immunoglobulin isotypes in gingival crevicular fluid: possible protective role of IgA.

Authors:  J T Grbic; R E Singer; H H Jans; R S Celenti; I B Lamster
Journal:  J Periodontol       Date:  1995-01       Impact factor: 6.993

9.  Lysosomal and cytoplasmic enzyme activity, crevicular fluid volume, and clinical parameters characterizing gingival sites with shallow to intermediate probing depths.

Authors:  I B Lamster; D S Harper; L A Fiorello; R L Oshrain; R S Celenti; J M Gordon
Journal:  J Periodontol       Date:  1987-09       Impact factor: 6.993

10.  A longitudinal study of aspartate aminotransferase in human gingival crevicular fluid.

Authors:  D A Chambers; P B Imrey; R L Cohen; J M Crawford; M E Alves; T A McSwiggin
Journal:  J Periodontal Res       Date:  1991-03       Impact factor: 4.419

View more
  4 in total

1.  Childhood overweight-obesity and periodontal diseases: is there a real correlation?

Authors:  Gian Luca Sfasciotti; Roberta Marini; Andrea Pacifici; Gaetano Ierardo; Luciano Pacifici; Antonella Polimeni
Journal:  Ann Stomatol (Roma)       Date:  2017-01-10

2.  Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

Authors:  T Maekawa; G Hajishengallis
Journal:  J Periodontal Res       Date:  2014-02-01       Impact factor: 4.419

3.  Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation.

Authors:  Atul Sharma; Tvsvgk Tilak; Sameer Bakhshi; Vinod Raina; Lalit Kumar; SurendraPal Chaudhary; RanjitKumar Sahoo; Ritu Gupta; Sanjay Thulkar
Journal:  ESMO Open       Date:  2017-02-13

4.  Long-term effect of Lactobacillus brevis CD2 (Inersan®) and/or doxycycline in aggressive periodontitis.

Authors:  Mishal Piyush Shah; Sheela Kumar Gujjari; Veerendrakumar Siddhpur Chandrasekhar
Journal:  J Indian Soc Periodontol       Date:  2017 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.